Clinical trial

Effects of a Probiotic on Oral Microbiota and Glycemic Control in Type 2 Diabetics; A Randomized Clinical Trial

NCT04913909

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIETARY_SUPPLEMENT · Unmapped registry intervention Effects of an oral probiotic or placebo use on oral microbiota and glycemic index in Type 2 diabetic patients Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of a Probiotic on Oral Microbiota and Glycemic Control in Type 2 Diabetics; A Randomized Clinical Trial

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-09-10

PhaseNA

Conditions

Diabetes Mellitus,Type 2candidate · MONDO: type 2 diabetes mellitus

Periodontitisverified · MONDO: periodontitis

Interventions

Effects of an oral probiotic or placebo use on oral microbiota and glycemic index in Type 2 diabetic patientsDIETARY_SUPPLEMENT

Sponsors & collaborators

Istanbul Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04913909 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.